Efficacy of subsequent therapies in patients (pts) with advanced ovarian cancer (AOC) in the phase III PAOLA-1/ENGOT-ov25 trial according to whether disease progression occurred during or after the end of olaparib (ola) maintenance

P Harter; MA Mouret-Reynier; D Lorusso; C Cropet; EM Guerra; Pia Wolfrum-Ristau; T Matsumoto; I Vergote; N Colombo; JU Maenpaa; C Lebreton; N de Gregorio; AM Mosconi; MJ Rubio-Perez; H Bourgeois; PA Fasching; AC Hardy-Bessard; D Denschlag; E Pujade-Lauraine; IL Ray-Coquard

Efficacy of subsequent therapies in patients (pts) with advanced ovarian cancer (AOC) in the phase III PAOLA-1/ENGOT-ov25 trial according to whether disease progression occurred during or after the end of olaparib (ola) maintenance

P Harter, MA Mouret-Reynier, D Lorusso, C Cropet, EM Guerra, Pia Wolfrum-Ristau, T Matsumoto, I Vergote, N Colombo, JU Maenpaa, C Lebreton, N de Gregorio, AM Mosconi, MJ Rubio-Perez, H Bourgeois, PA Fasching, AC Hardy-Bessard, D Denschlag, E Pujade-Lauraine, IL Ray-Coquard

Universitätsklinik für Frauenheilkunde und Geburtshilfe

Publikation: Beitrag in Fachzeitschrift › publizierter Abstrakt (Zeitschrift) › Begutachtung

Originalsprache	Englisch
Fachzeitschrift	JOURNAL OF CLINICAL ONCOLOGY
Jahrgang	41
Ausgabenummer	16
Publikationsstatus	Veröffentlicht - 2023

Dieses zitieren

Harter, P., Mouret-Reynier, MA., Lorusso, D., Cropet, C., Guerra, EM., Wolfrum-Ristau, P., Matsumoto, T., Vergote, I., Colombo, N., Maenpaa, JU., Lebreton, C., de Gregorio, N., Mosconi, AM., Rubio-Perez, MJ., Bourgeois, H., Fasching, PA., Hardy-Bessard, AC., Denschlag, D., Pujade-Lauraine, E., & Ray-Coquard, IL. (2023). Efficacy of subsequent therapies in patients (pts) with advanced ovarian cancer (AOC) in the phase III PAOLA-1/ENGOT-ov25 trial according to whether disease progression occurred during or after the end of olaparib (ola) maintenance. JOURNAL OF CLINICAL ONCOLOGY , 41(16).

Harter, P ; Mouret-Reynier, MA ; Lorusso, D et al. / Efficacy of subsequent therapies in patients (pts) with advanced ovarian cancer (AOC) in the phase III PAOLA-1/ENGOT-ov25 trial according to whether disease progression occurred during or after the end of olaparib (ola) maintenance. in: JOURNAL OF CLINICAL ONCOLOGY 2023 ; Jahrgang 41, Nr. 16.

@article{3915018aa7664f67865d1f9a1328be5e,

title = "Efficacy of subsequent therapies in patients (pts) with advanced ovarian cancer (AOC) in the phase III PAOLA-1/ENGOT-ov25 trial according to whether disease progression occurred during or after the end of olaparib (ola) maintenance",

author = "P Harter and MA Mouret-Reynier and D Lorusso and C Cropet and EM Guerra and Pia Wolfrum-Ristau and T Matsumoto and I Vergote and N Colombo and JU Maenpaa and C Lebreton and {de Gregorio}, N and AM Mosconi and MJ Rubio-Perez and H Bourgeois and PA Fasching and AC Hardy-Bessard and D Denschlag and E Pujade-Lauraine and IL Ray-Coquard",

year = "2023",

language = "English",

volume = "41",

journal = "JOURNAL OF CLINICAL ONCOLOGY ",

issn = "0732-183X",

publisher = "Lippincott Williams & Wilkins ",

number = "16",

}

Harter, P, Mouret-Reynier, MA, Lorusso, D, Cropet, C, Guerra, EM, Wolfrum-Ristau, P, Matsumoto, T, Vergote, I, Colombo, N, Maenpaa, JU, Lebreton, C, de Gregorio, N, Mosconi, AM, Rubio-Perez, MJ, Bourgeois, H, Fasching, PA, Hardy-Bessard, AC, Denschlag, D, Pujade-Lauraine, E & Ray-Coquard, IL 2023, 'Efficacy of subsequent therapies in patients (pts) with advanced ovarian cancer (AOC) in the phase III PAOLA-1/ENGOT-ov25 trial according to whether disease progression occurred during or after the end of olaparib (ola) maintenance', JOURNAL OF CLINICAL ONCOLOGY , Jg. 41, Nr. 16.

Efficacy of subsequent therapies in patients (pts) with advanced ovarian cancer (AOC) in the phase III PAOLA-1/ENGOT-ov25 trial according to whether disease progression occurred during or after the end of olaparib (ola) maintenance. / Harter, P; Mouret-Reynier, MA; Lorusso, D et al.
in: JOURNAL OF CLINICAL ONCOLOGY , Jahrgang 41, Nr. 16, 2023.

Publikation: Beitrag in Fachzeitschrift › publizierter Abstrakt (Zeitschrift) › Begutachtung

TY - JOUR

T1 - Efficacy of subsequent therapies in patients (pts) with advanced ovarian cancer (AOC) in the phase III PAOLA-1/ENGOT-ov25 trial according to whether disease progression occurred during or after the end of olaparib (ola) maintenance

AU - Harter, P

AU - Mouret-Reynier, MA

AU - Lorusso, D

AU - Cropet, C

AU - Guerra, EM

AU - Wolfrum-Ristau, Pia

AU - Matsumoto, T

AU - Vergote, I

AU - Colombo, N

AU - Maenpaa, JU

AU - Lebreton, C

AU - de Gregorio, N

AU - Mosconi, AM

AU - Rubio-Perez, MJ

AU - Bourgeois, H

AU - Fasching, PA

AU - Hardy-Bessard, AC

AU - Denschlag, D

AU - Pujade-Lauraine, E

AU - Ray-Coquard, IL

PY - 2023

Y1 - 2023

M3 - published Abstract (Journal)

SN - 0732-183X

VL - 41

JO - JOURNAL OF CLINICAL ONCOLOGY

JF - JOURNAL OF CLINICAL ONCOLOGY

IS - 16

ER -

Harter P, Mouret-Reynier MA, Lorusso D, Cropet C, Guerra EM, Wolfrum-Ristau P et al. Efficacy of subsequent therapies in patients (pts) with advanced ovarian cancer (AOC) in the phase III PAOLA-1/ENGOT-ov25 trial according to whether disease progression occurred during or after the end of olaparib (ola) maintenance. JOURNAL OF CLINICAL ONCOLOGY . 2023;41(16).